Approach A) Increase revenues, production capacity and stock step by step and gradually while, also gradually, adding more outlets and regions to the sales channels. Change strategy as required. Adapt and modify strategy, stock, distributors in iterations. The risk profile for this approach is comparatively low. And it builds a long-term regular customer base before bigger steps are taken.
Approach B) Fire up production quickly, stock lots of product, raise capital for a big advertising campaign, make deals with lots of distributors, then cross your fingers and hope it works. If the ad campaign doesn't work or the product doesn't sell, more capital is required. Risk for company and shareholders is high.
So far, Cellmid/Advangen have, in my view, mostly followed approach A. I am sure that with increased demand and success, new channels will be added. Being successful and present globally is the ULTAmate goal, but I prefer the current approach than an "all-in" one.
CDY Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held
